Seth Klarman Atara Biotherapeutics, Inc. Transaction History

Baupost Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.5 - $3.04 $975,000 - $1.98 Million	650,000 Added 7.12%	9,773,616 $15.7 Million
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $2.8 Million - $5.46 Million	1,000,000 Added 12.31%	9,123,616 $26.5 Million
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $2.99 Million - $5.98 Million	-353,872 Reduced 4.17%	8,123,616 $75.5 Million
Q1 2021 May 14, 2021	SELL	$14.0 - $20.72 $8.84 Million - $13.1 Million	-631,500 Reduced 6.93%	8,477,488 $122 Million
Q4 2020 Feb 12, 2021	SELL	$12.67 - $26.23 $10.3 Million - $21.3 Million	-813,042 Reduced 8.19%	9,108,988 $179 Million

Q2 2020 Aug 13, 2020	BUY	$7.53 - $14.93 $12.1 Million - $24.1 Million	1,613,130 Added 19.41%	9,922,030 $145 Million
Q3 2019 Nov 13, 2019	BUY	$12.03 - $19.94 $15.7 Million - $26.1 Million	1,308,900 Added 18.7%	8,308,900 $117 Million
Q2 2019 Aug 13, 2019	BUY	$19.05 - $41.04 $11.8 Million - $25.4 Million	619,481 Added 9.71%	7,000,000 $141 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $41.74 $3.58 Million - $5.25 Million	125,887 Added 2.01%	6,380,519 $254 Million
Q1 2018 May 14, 2018	BUY	$18.0 - $48.35 $16.1 Million - $43.3 Million	895,000 Added 16.7%	6,254,632 $244 Million
Q3 2017 Nov 13, 2017	BUY	$13.25 - $17.05 $71 Million - $91.4 Million	5,359,632	5,359,632 $88.7 Million

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Baupost Group LLC, based on Form 13F filings with the SEC.

Stay updated on Baupost Group LLC and Seth Klarman with notifications on news.